Evidence map›Paper›PMID 28514688›Full record

ArticleImmunity2017

The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development.

Masaki Miyazaki, Kazuko Miyazaki, Kenian Chen, Yi Jin, Jacob Turner, Amanda J Moore, Rintaro Saito, Kenichi Yoshida, Seishi Ogawa, Hans-Reimer Rodewald and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Masaki MiyazakiDepartment of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan; Department of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: mmiyazaki@infront.kyoto-u.ac.jp.
Kazuko MiyazakiDepartment of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan; Department of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA.
Kenian ChenBaylor Research Institute, Baylor Institute for Immunology Research, Dallas, TX 75246, USA.
Yi JinBaylor Research Institute, Baylor Institute for Immunology Research, Dallas, TX 75246, USA.
Jacob TurnerBaylor Research Institute, Baylor Institute for Immunology Research, Dallas, TX 75246, USA.
Amanda J MooreDepartment of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA.
Rintaro SaitoInstitute of Metabolomic Medicine and Center for Renal Translational Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Kenichi YoshidaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto 606-8507, Japan.
Seishi OgawaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto 606-8507, Japan.
Hans-Reimer RodewaldDivision of Cellular Immunology, German Cancer Research Center, Im Neuenheimer Field 280, 69120 Heidelberg, Germany.
Yin C LinBaylor Research Institute, Baylor Institute for Immunology Research, Dallas, TX 75246, USA.
Hiroshi KawamotoDepartment of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Cornelis MurreDepartment of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: murre@biomail.ucsd.edu.
Baylor University · USKyoto University · JPUniversity of California, San Diego · USHeidelberg University · DE

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI CORNELIS MURRE · 2014 to 2026
$26.3M
NIAID NIH HHS P01 AI102853
6 · The paper itself

Abstract

Innate and adaptive lymphoid development is orchestrated by the activities of E proteins and their antagonist Id proteins, but how these factors regulate early T cell progenitor (ETP) and innate lymphoid cell (ILC) development remains unclear. Using multiple genetic strategies, we demonstrated that E proteins E2A and HEB acted in synergy in the thymus to establish T cell identity and to suppress the aberrant development of ILCs, including ILC2s and lymphoid-tissue-inducer-like cells. E2A and HEB orchestrated T cell fate and suppressed the ILC transcription signature by activating the expression of genes associated with Notch receptors, T cell receptor (TCR) assembly, and TCR-mediated signaling. E2A and HEB acted in ETPs to establish and maintain a T-cell-lineage-specific enhancer repertoire, including regulatory elements associated with the Notch1, Rag1, and Rag2 loci. On the basis of these and previous observations, we propose that the E-Id protein axis specifies innate and adaptive lymphoid cell fate.

Indexed as

Adaptive ImmunityImmunity, InnateImmunomodulationAnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCluster AnalysisGene ExpressionGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksImmunophenotypingInhibitor of Differentiation Protein 2Lymphocyte ActivationLymphocyte SubsetsLymphoid Progenitor CellsBasic Helix-Loop-Helix ProteinsInhibitor of Differentiation Protein 2Tcf3 protein, mousebasic helix-loop-helix transcription factorE2Aearly T cell progenitorE-ID protein axisHEBinnate lymphoid cellNotch signalingregulomeT cell development

Identifiers

PMID28514688
PMCPMC5512722
OpenAlexW2615441390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.